SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

2025 AGM Results Statement

2 Dec 2025 16:44

RNS Number : 9471J
JPEL Private Equity Limited
02 December 2025
 

JPEL Private Equity Limited

Fourth Floor

Plaza House

Admiral Park, St Peter Port

Guernsey, GY1 4BF

www.jpelonline.com

 

 

JPEL ANNOUNCES RESULTS OF AGM

AND BOARD SUCCESSION

 

 

* * *

 

GUERNSEY, 2 DECEMBER 2025

 

JPEL Private Equity Limited (the "Company") announces that at the Annual General Meeting ("AGM") of the Company held on 2 December 2025, all resolutions put to shareholders at the AGM were duly passed.

 

SUMMARY OF RESOLUTIONS PROPOSED AT AGM

 

 

Special Resolutions

1. To renew the Company's authority to make purchases of up to 15 per cent. of its own issued US$ Equity Shares pursuant to any proposed Tender Offer.

2. To renew the Company's general authority to make market purchases of up to 14.99 per cent. of the US$ Equity Shares.

 

Ordinary Resolutions

3. To approve and adopt the Annual Report and Financial Statements of the Company for the year ended 30 June 2025.

4. To re-elect PricewaterhouseCoopers CI LLP as Auditors to the Company.

5. To re-authorise the Directors to determine the Auditors' remuneration.

6. To re-authorise and agree the remuneration of the Directors in accordance with the Articles of Incorporation.

7. To re-elect Trina Le Noury as a non-executive, independent director of the Company.

8. To re-elect Anthony (Tony) Dalwood as a non-executive, independent director of the Company.

 

 

 

Below, please find a summary of all votes received for JPEL's AGM: 

 

In Favour

Discretion

Against

Withheld

Resolution

Votes

%

Items

Votes

%

Items

Votes

%

Items

Votes

Items

1

15,561,578

100

14

0

0

0

0

0

0

496,448

1

2

15,561,578

100

14

0

0

0

0

0

0

496,448

1

3

15,561,578

100

14

0

0

0

0

0

0

496,448

1

4

15,561,578

100

14

0

0

0

0

0

0

496,448

1

5

15,561,578

100

14

0

0

0

0

0

0

496,448

1

6

15,561,578

100

14

0

0

0

0

0

0

496,448

1

7

15,335,078 

98.54

13

0

0

0

226,500

1.46

1

496,448

1

8

12,233,887 

78.62

12

0

0

0

3,327,691

21.38

2

496,448

1

 

NB: Percentage of Votes cast excludes Withheld votes and resolution 9 (relating to the re-election of Sean Hurst) was withdrawn from the meeting. The Board acknowledges that there was a significant minority vote (being in excess of 20 per cent) against resolution 8, and will duly engage with shareholders in relation to this matter.

 

* * *

 

 Board Succession

In light of two of the three Board directors having served for at least nine years a process is underway to refresh its configuration. In order to ensure an orderly Board succession plan, this process is anticipated to be completed within six months. The Board remains mindful of its fiduciary duties to all shareholders including its commitment to focus on minimising costs appropriately. 

 

As a first stage of this orderly transition, Sean Hurst had notified the Company of his intention to step-down from his position prior to the AGM with immediate effect. The Board and Manager would like to thank Sean for his valuable contribution during his time as Chair and wish him all the best in his future endeavours.

 

Tony Dalwood has been appointed Chair with immediate effect to oversee the succession plan. Trina Le Noury remains Chair of the Audit committee.

 

The appointment of additional Non-Executive Directors is progressed and, subject to completion of the relevant regulatory approvals, at least one new Director will join the Board shortly. A further update will be provided in due course.

 

About JPEL Private Equity Limited

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQLLFBELLZFBX
Date   Source Headline
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.